Location · Salt Lake City, UT
Clinical trials in Salt Lake City, UT
319 recruiting studies have a site in the Salt Lake City area, and 97 of them accept healthy volunteers. The area includes West Valley City, Murray, Sandy, South Jordan, West Jordan, Draper and nearby cities.
319 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
More recruiting studies (pay not posted)
- RecruitingPhase 4
SUMMIT RISE Study of Acute Ischemic Stroke Patients
Route 92 Medical, Inc.
- Location
- West Jordan, UT
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)
Direct Biologics, LLC
- Location
- Phoenix, AZ + 30 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism
Halozyme Therapeutics
- Location
- Los Angeles, CA + 19 other US sites
- Eligibility basics
- Ages 12–17 · Men only
- RecruitingPhase 2
A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
Karyopharm Therapeutics Inc
- Location
- Duarte, CA + 6 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Sun Pharmaceutical Industries, Inc.
- Location
- Birmingham, AL + 53 other US sites
- Eligibility basics
- Ages 12–17
- RecruitingPhase 3
A Study to Evaluate the Safety, Efficacy, PK, PD and Immunogenicity of Cipaglucosidase Alfa/Miglustat in IOPD Subjects Aged 0 to <18
Amicus Therapeutics
- Location
- Gainesville, FL + 5 other US sites
- Eligibility basics
- Up to age 17
- RecruitingPhase 3
PF614 Analgesic Activity in Acute Postoperative Pain (PF614-301)
Ensysce Biosciences
- Location
- Atlanta, GA + 2 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 2
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
Autobahn Therapeutics, Inc.
- Location
- Birmingham, AL + 31 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingPhase 2
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
Deciphera Pharmaceuticals, LLC
- Location
- Duarte, CA + 25 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
Orbit Study: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Intrathecally Administered ION356 in Participants With Pelizaeus Merzbacher Disease (PMD)
Ionis Pharmaceuticals, Inc.
- Location
- Atlanta, GA + 2 other US sites
- Eligibility basics
- Ages 2–17 · Men only
- Recruiting
Melodi Matrix™ in Breast Reconstruction
Melodi Health, Inc.
- Location
- Palo Alto, CA + 9 other US sites
- Eligibility basics
- Ages 22+ · Women only
- RecruitingPhase 3
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
Mezzion Pharma Co. Ltd
- Location
- Phoenix, AZ + 34 other US sites
- Eligibility basics
- Ages 12–18
- RecruitingPhase 3
A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer
Energenesis Biomedical Co., Ltd.
- Location
- Miami, FL + 9 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
Kartos Therapeutics, Inc.
- Location
- Birmingham, AL + 57 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Saline Enhanced Radiofrequency (SERF) Needle Ablation for Refractory VT
Thermedical, Inc.
- Location
- Salt Lake City, UT
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus
GIE Medical
- Location
- Scottsdale, AZ + 32 other US sites
- Eligibility basics
- Ages 22+
- RecruitingPhase 3
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel
GIE Medical
- Location
- Scottsdale, AZ + 30 other US sites
- Eligibility basics
- Ages 22+
- RecruitingPhase 2/Phase 3
Safety and Efficacy of Tideglusib in Congenital or Childhood Onset Myotonic Dystrophy
AMO Pharma Limited
- Location
- Little Rock, AR + 5 other US sites
- Eligibility basics
- Ages 6–45
- RecruitingPhase 2
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
aTyr Pharma, Inc.
- Location
- Los Angeles, CA + 12 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
InfasurfAero™ Versus Sham Treatment in Preterm Newborns With RDS
ONY
- Location
- Phoenix, AZ + 9 other US sites
- Eligibility basics
- Ages 7 mo–8 mo
- RecruitingEarly Phase 1
A Phase 1 Study of ARC-001 in Participants Undergoing Third Molar Extraction
Arcato Laboratories, Inc.
- Location
- Salt Lake City, UT
- Eligibility basics
- Ages 18–55
- Recruiting
PARTNER 3 Trial - Aortic Valve-in-Valve
Edwards Lifesciences
- Location
- Phoenix, AZ + 28 other US sites
- Eligibility basics
- Any age listed
- RecruitingHealthy volunteersPhase 3
Basal Cell Carcinoma Chemoprevention Trial
VA Office of Research and Development
- Location
- San Diego, CA + 5 other US sites
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteers
Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network
National Human Genome Research Institute (NHGRI)
- Location
- Birmingham, AL + 23 other US sites
- Eligibility basics
- Ages 1 mo–100